Analysed REVOLUTION MEDICINES INC (RVMD:NASDAQ) News Sources
IBT manager on therapeutics conference, oncology breakthroughs and five years of outperformance
15-10-2026
yahoo.com
VSTM Stock Clocks Best Day In 11 Months After Positive Cancer Drug Trial Update And Multiple Price-Target Hikes
15-10-2026
stocktwits.com
Revolution Medicines Begins Treating Patients in Phase 3 RASolve 308 Trial Evaluating Zoldonrasib in Combination with Pembrolizumab and Chemotherapy as First-Line Treatment for Patients with Metastatic RAS G12D Non-Squamous Non-Small Cell Lung Cancer
20-10-2026
yahoo.com
Revolution Medicines (RVMD) Has an Approved Cancer Drug. Can Its $38 Billion Valuation Deliver?
20-10-2026
yahoo.com
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
21-10-2026
yahoo.com
Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026
21-10-2026
yahoo.com
What is the current price of REVOLUTION MEDICINES INC (RVMD:NASDAQ)?
The current price of REVOLUTION MEDICINES INC (RVMD:NASDAQ) is $186.99.
REVOLUTION MEDICINES INC (RVMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of REVOLUTION MEDICINES INC (RVMD:NASDAQ) since the previous trading day is $-0.7.
REVOLUTION MEDICINES INC (RVMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of REVOLUTION MEDICINES INC (RVMD:NASDAQ) since the previous trading day is -0.373%.
What is the most recent average sentiment score for REVOLUTION MEDICINES INC (RVMD:NASDAQ)?
The most recent average sentiment score for REVOLUTION MEDICINES INC (RVMD:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for REVOLUTION MEDICINES INC (RVMD:NASDAQ)?
The most recent sentiment for REVOLUTION MEDICINES INC (RVMD:NASDAQ) is .
SEC-8K** Filing Available For REVOLUTION MEDICINES INC (RVMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.